• Japanese
  • Korean
  • Chinese
Cover Image

The United States Rheumatic Diseases Therapeutics Market

Abstract

Changes on the Horizon with Novel Oral Therapies for Musculoskeletal Indications

This research service covers the therapeutics for rheumatic diseases market in the United States from 2009 to 2017, with 2011 as the base year. The focus of this research is on biologics and other treatments prescribed as add-on therapies for rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS); background standard of care therapies are not covered in this study. Included in the study are products already on the market and products in development as well as patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. The market is segmented by disease indication: RA, PsA, and AS.

Key Questions This Study Will Answer

  • Is the market growing, how long will it continue to grow, and at what rate?
  • Is this a consolidated or diverse market? How will the structure evolve?
  • What are the unmet needs? How can emerging competitors meet these needs?
  • How will new agents fit into the treatment paradigm?
  • What are the major trends affecting the growth of this market? What are the risks for participants or potential participants?

Table of Contents

1. Rheumatic Diseases Therapeutics Market

Analysis of the United States Rheumatic Diseases Therapeutics Market

  • Executive Summary and Market Overview

2. Rheumatic Diseases Therapeutics Market - Total Market

Analysis of the Total Rheumatic Diseases Therapeutics Market

  • Drivers and Restraints
  • Forecasts and Trends
  • Demand Analysis
  • Market Share and Competitive Analysis

3. Rheumatoid Arthritis Segment

Analysis of the Rheumatoid Arthritis Segment

  • Segment Breakdown and Market Engineering Measurements
  • Patient Forecast
  • Pricing Trends and Forecast
  • Revenue Forecast
  • Market Share Analysis

4. Psoriatic Arthritis Segment

Analysis of the Psoriatic Arthritis Segment

  • Segment Breakdown and Market Engineering Measurements
  • Patient Forecast
  • Pricing Trends and Forecast
  • Revenue Forecast
  • Market Share Analysis

5. Ankylosing Spondylitis Segment

Analysis of the Ankylosing Spondylitis Segment

  • Segment Breakdown and Market Engineering Measurements
  • Patient Forecast
  • Pricing Trends and Forecast
  • Revenue Forecast
  • Market Share Analysis

6. The Last Word

The Last Word

  • Summary and Conclusions

7. Appendix

Appendix

  • Appendix
Show More
Pricing
Get Notified
Email me when related reports are published